Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2024-05-24
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-protein Formula Supplements in Chronic Kidney Disease
NCT05318014
Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease
NCT00364884
The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status
NCT02046746
Low Protein Diet, Gut Microbiome and Chronic Kidney Disease
NCT05019599
Effects of Low Protein Diet in Preventing the Progression of Chronic Kidney Disease(CKD)---a Prospective Study
NCT02886975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Low-protein diet strategies combined with AC-134 capsules
Low protein diet with AC-134
Low protein diet combined with AC-134 Dosage: 2 capsules,three times/day
Control group
Low-protein diet strategies
Standard treatment
Low protein diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low protein diet with AC-134
Low protein diet combined with AC-134 Dosage: 2 capsules,three times/day
Standard treatment
Low protein diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with stage 3-5 chronic kidney disease, excluding dialysis patients.
* Signed informed consent is required before enrollment.
Exclusion Criteria
* Pregnant or lactating women.
* Patients who have undergone kidney transplantation.
* Obstructive nephropathy within the past month.
* Acute kidney injury within the past three months.
* Gastrointestinal bleeding or severe constipation within the past three months.
* Patients with active malignancy within the past two years.
* Severe cardiovascular diseases such as congestive heart failure New York class III-IV or cerebrovascular disease
* Severe liver disease, such as liver cirrhosis with ascites.
* Active infectious disease
20 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
All Clean Health Co., Ltd
UNKNOWN
Taichung Veterans General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cheng-Hsu Chen, MDPHD
Role: PRINCIPAL_INVESTIGATOR
Division of Nephrology in Taichung Veterans General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taichung Veterans General Hospital
Taichung, ROC, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SF23520C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.